Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078491 · ClinicalTrials.gov registry record · NA
Technological Advances in Glucose Management in Older Adults
A NA study of Type 1 Diabetes Mellitus and Hypoglycemia, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT03078491: Completed NA study of Type 1 Diabetes Mellitus and Hypoglycemia, sponsored by Joslin Diabetes Center.
NCT03078491 is a NA study of Type 1 Diabetes Mellitus and Hypoglycemia that has completed, run by Joslin Diabetes Center. The registered enrollment target is 168 participants, roughly in line with the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03078491, a NA study of Type 1 Diabetes Mellitus and Hypoglycemia, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to assess the effectiveness of CGM (Continuous Glucose Monitor), enhanced by a diabetes management platform (DMP), collectively called enhanced CGM (eCGM), in the care of older patients with T1D. The DMP includes an automated data transfer from CGM, insulin-delivery devices, and activity tracker to a clinical decision support system (CDS) that provides dosing adjustment recommendations based on that data to the healthcare team. In addition, the DMP includes on-demand education for patients and caregivers, and an interface for communication between providers, patients, and their caregivers.
Primary Outcome
Minutes per day CGM \< 70 mg/dL assessed over 2 weeks CGM use (blinded in the control arm; unblinded in the treatment arm)
Conditions Studied
Interventions
- OTHER eCGM (enhanced CGM)
Study Locations (1)
Massachusetts
- Joslin Diabetes Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2022-10-01 |
| Phase | NA |
What the finished NCT03078491 record still lists
NCT03078491 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target.
The record links to 3 conditions, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which eCGM (enhanced CGM) is the first listed.
NCT03078491 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03078491 about?
NCT03078491 is a clinical study titled "Technological Advances in Glucose Management in Older Adults". This is a study to assess the effectiveness of CGM (Continuous Glucose Monitor), enhanced by a diabetes management platform (DMP), collectively called enhanced CGM (eCGM), in the care of older patients with T1D. The DMP includes an automated data transfer from CGM, insulin-delivery devices, and acti...
What is the current status of trial NCT03078491?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2017-03-30. Estimated completion is 2022-10-01.
What conditions does trial NCT03078491 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus, Hypoglycemia, Older Adults.
What interventions are being tested in trial NCT03078491?
The interventions under investigation include: eCGM (enhanced CGM) (OTHER).
Who is sponsoring clinical trial NCT03078491?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03078491 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03078491's enrollment target sits among peer trials
168 20th of 112 higher than 93 of 112 other Type 1 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI